EAM
ACOR

Eagle Asset Management’s Acorda Therapeutics ACOR Stock Holding History

Eagle Asset Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,824
Closed -$17.6M – 680
2016
Q4 		$17.6M Sell
7,824
-5,775
-42% -$13.7M 0.12% 240
2016
Q3 		$34.1M Buy
13,599
+335
+3% +$1,000K 0.23% 136
2016
Q2 		$40.6M Sell
13,264
-613
-4% -$1.99M 0.28% 113
2016
Q1 		$44M Sell
13,877
-1,028
-7% -$4.27M 0.31% 104
2015
Q4 		$76.5M Sell
14,905
-1,320
-8% -$5.77M 0.51% 43
2015
Q3 		$51.6M Sell
16,225
-3,525
-18% -$13.7M 0.35% 92
2015
Q2 		$79M Sell
19,750
-767
-4% -$2.96M 0.44% 70
2015
Q1 		$81.9M Sell
20,517
-1,081
-5% -$4.95M 0.47% 61
2014
Q4 		$106M Buy
21,598
+994
+5% +$4.27M 0.61% 36
2014
Q3 		$83.8M Buy
20,604
+675
+3% +$2.53M 0.48% 59
2014
Q2 		$80.6M Buy
19,929
+2,349
+13% +$9.58M 0.44% 68
2014
Q1 		$80M Sell
17,580
-28
-0.2% -$113K 0.44% 54
2013
Q4 		$61.7M Sell
17,608
-846
-5% -$3.3M 0.35% 91
2013
Q3 		$76.9M Buy
18,454
+1,475
+9% +$6.35M 0.38% 75
2013
Q2 		$67.2M Buy
+16,979
New +$69.9M 0.45% 54

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Eagle Asset Management's ACOR Position: Q1 2017 in Review

Eagle Asset Management sold out of Acorda Therapeutics (ACOR) in Q1 2017, closing a stake of 7,824 shares — an estimated $17.6M sold.

Eagle Asset Management first reported a position in ACOR in Q2 2013 and held it in 15 quarters. The position peaked at $106M in Q4 2014. 178 funds tracked by Wall St. Rank hold ACOR as of Q1 2017.

  • Eagle Asset Management reported no remaining Acorda Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Eagle Asset Management sold 7,824 Acorda Therapeutics shares in Q1 2017, an estimated $17.6M.
  • Eagle Asset Management first reported a position in Acorda Therapeutics in Q2 2013 and held it in 15 quarters.
  • Eagle Asset Management's Acorda Therapeutics position peaked at $106M in Q4 2014.
  • 178 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2017.

Based on Eagle Asset Management's 13F filing for Q1 2017, filed 5 May 2017.